Bektas Delal, De Maria Lucio, Graepel Stephen, Lanzino Giuseppe, Flemming Kelly D
Department of Neurosurgery, Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA.
Department of Neurosurgery, University Hospital Zurich, Frauenklinikstrasse 10, Zurich, 8091, Switzerland.
Neurosurg Rev. 2025 Apr 24;48(1):381. doi: 10.1007/s10143-025-03535-9.
Data on the natural history and management of cerebellar cavernous malformations (CMs) is limited. This study aims to identify factors associated with hemorrhage risk, assess management strategies, and compare outcomes between conservative and surgical management in patients with cerebellar CMs.
We retrospectively reviewed 130 patients with cerebellar CMs treated at our center (1990-2023). Data on clinical presentation, lesion characteristics, management strategies, and outcomes were analyzed. Annual hemorrhage risk was calculated. Surgical outcomes were assessed based on the persistence of CM-related symptoms and the presence of postoperative complications. Statistical analyses identified factors associated with hemorrhage, symptomatic presentation, and surgical outcomes.
Of 130 patients (53.8% female; median age of 48.5 years (IQR: 26.75)), 41 (31.5%) presented with hemorrhage, and 20 (15.4%) had focal neurological deficits. Median lesion size measured 12 mm (IQR 8 mm) in size and were primarily located in the hemispheres (n = 89, 68.5%), with fewer in the vermis (n = 21, 16.2%), peduncle (n = 20, 15.4%), and dentate nucleus (n = 9, 6.9%). The annual hemorrhage risk for incidental lesions was 1.19%, while rehemorrhage risk for initially hemorrhagic lesions was 8.35%. Surgery was performed in 31 patients (23.8%), mostly for hemorrhage (n = 15, 48.4%) or cerebellar symptoms (n = 7, 22.6%). Postoperative complications were reported in three patients. At a median follow-up of 1.11 years (IQR 5.15 years), 22 patients (18.2%) had persistent symptoms, two developed new symptoms, and two experienced worsening symptoms from hypertrophic olivary degeneration. There was no CM- related mortality, and only one patient experienced moderate CM-related disability (mRS = 3).
Cerebellar CMs generally have a benign course with hemorrhage risks compared to supratentorial and brainstem lesions. Conservative management is recommended for incidental lesions, while surgery should be reserved for symptomatic, accessible cases.
关于小脑海绵状血管畸形(CMs)自然史及治疗的数据有限。本研究旨在确定与出血风险相关的因素,评估治疗策略,并比较小脑CMs患者保守治疗和手术治疗的效果。
我们回顾性分析了1990年至2023年在本中心接受治疗的130例小脑CMs患者。分析了临床表现、病变特征、治疗策略及治疗效果等数据。计算年出血风险。根据CM相关症状的持续情况及术后并发症的发生情况评估手术效果。通过统计分析确定与出血、症状表现及手术效果相关的因素。
130例患者中(女性占53.8%;中位年龄48.5岁(四分位间距:26.75)),41例(31.5%)出现出血,20例(15.4%)有局灶性神经功能缺损。病变大小中位值为12mm(四分位间距8mm),主要位于半球(n = 89,68.5%),位于蚓部(n = 21,16.2%)、脑桥臂(n = 20,15.4%)和齿状核(n = 9,6.9%)的较少。偶然发现病变的年出血风险为1.19%,最初出血性病变的再出血风险为8.35%。31例患者(23.8%)接受了手术,主要是因为出血(n = 15,48.4%)或小脑症状(n = 7,22.6%)。3例患者报告有术后并发症。中位随访时间为1.11年(四分位间距5.15年),22例患者(18.2%)有持续症状,2例出现新症状,2例因肥大性橄榄核变性症状加重。无与CM相关的死亡病例,仅有1例患者有中度CM相关残疾(改良Rankin量表评分=3)。
与幕上和脑干病变相比,小脑CMs通常病程良性,有出血风险。对于偶然发现的病变,建议保守治疗,而手术应仅用于有症状、可手术的病例。